APA (7th ed.) Citation

EB, C., B, H., J, A., AH, L., E, G., C, C., . . . J, G. (2020). Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71(7), e115. https://doi.org/10.1093/cid/ciz1089

Chicago Style (17th ed.) Citation

EB, Cunningham, et al. "Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 71, no. 7 (2020): e115. https://doi.org/10.1093/cid/ciz1089.

MLA (9th ed.) Citation

EB, Cunningham, et al. "Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 71, no. 7, 2020, p. e115, https://doi.org/10.1093/cid/ciz1089.